Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Therapeutic strategies in common variable immunodeficiency.

W A Carrock Sewell1, Matthew Buckland, Stephen R A Jolles

  • 1Path Links Immunology, Scunthorpe General Hospital, Scunthorpe, Lincolnshire, UK.

Drugs
|June 27, 2003
PubMed
Summary

Early recognition and immunoglobulin replacement are key for common variable immunodeficiency (CVID) treatment. Research is ongoing for other therapies and optimal management of CVID complications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quality of life of X-linked agammaglobulinemia patients in the United Kingdom.

Journal of human immunity·2026
Same author

Decreased IL-17-producing T<sub>H</sub> cells as a diagnostic marker for STAT signaling-related primary immunodeficiencies.

The journal of allergy and clinical immunology. Global·2026
Same author

Inborn errors of immunity: Manifestation, treatment, and outcome-an ESID registry 1994-2024 report on 30,628 patients.

Journal of human immunity·2025
Same author

Clinical presentation and management of 239 children and adolescents with hereditary angioedema.

The journal of allergy and clinical immunology. In practice·2025
Same author

Inborn errors of immunity: manifestation, treatment, and outcome - an ESID registry 1994-2024 report on 30,628 patients.

medRxiv : the preprint server for health sciences·2025
Same author

Global frequency, diagnosis, and treatment of hereditary angioedema with normal C1 inhibitor.

The journal of allergy and clinical immunology. Global·2025

Area of Science:

  • Immunology
  • Clinical Medicine

Background:

  • Common variable immunodeficiency (CVID) is a primary immunodeficiency characterized by impaired antibody production.
  • Current management focuses on immunoglobulin replacement and infection control.

Purpose of the Study:

  • To review current treatment strategies for CVID.
  • To highlight areas requiring further research in CVID management.

Main Methods:

  • Literature review of existing CVID treatment protocols and research.
  • Analysis of current practices in immunoglobulin replacement and complication management.

Main Results:

  • Immunoglobulin replacement therapy, while standard, lacks uniform protocols regarding administration route, dose, and frequency.

Related Experiment Videos

  • Interleukin-2 therapy shows potential but requires more evidence for routine use.
  • Treatment of suppurative lung disease in CVID parallels cystic fibrosis management.
  • Granulomatous complications in CVID necessitate further research for optimal therapeutic strategies.

    • Conclusions:

    • Optimal CVID treatment relies on early diagnosis, immunoglobulin replacement, and infection management.
    • Further research is crucial to standardize immunoglobulin therapy and develop effective treatments for CVID-associated complications, particularly granulomatous disease.